The control of immune response is operated by specialized cells, soluble molecules and membrane-bound signals, which modulate the intensity of immune reactivity and preside over the maintenance of homoeostasis. An imbalance between immunity and tolerance mechanisms can lead to pathological conditions, such as autoimmune diseases or neoplasia, characterized by excessive or deficient control of immune reactivity respectively. 
| INTRODUC TI ON
The control of immune response is operated by specialized cells, soluble molecules and membrane-bound signals, which modulate the intensity of immune reactivity and preside over the maintenance of homoeostasis. An imbalance between immunity and tolerance mechanisms can lead to pathological conditions, such as autoimmune diseases or neoplasia, characterized by excessive or deficient control of immune reactivity respectively. an interplay between metabolic and immunological events known as cellular immunometabolism. 4 In CD8α − DCs, the increased metabolism of specific amino acids and the subsequent production of regulatory catabolites critically contribute to the acquisition of a newly expressed suppressive phenotype. The amino acid degrading enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and arginase 1 (Arg1) are major components of immunometabolic pathways in DCs. 
| MATERIAL S AND ME THODS

| Mice
Eight-to ten-week-old female C57BL/6 mice were purchased from Charles River Breeding Laboratories and Ido1 −/− mice from the Jackson Laboratory. All in vivo studies were in compliance with National and Perugia University Animal Care and Use Committee guidelines.
| Dendritic cell purification, transfection and treatment
Splenic DCs were fractionated using positive selection columns combined with CD11c and CD8 MicroBeads (Miltenyi Biotec, Germany). 13 Purified CD8α − DCs were transfected by DOTAP (Roche, USA) with IL-35Ig or control Ig gene constructs 3 and incubated overnight before in vitro analysis or in vivo administration.
Nω-hydroxy-nor-Arg (nor-NOHA; Bachem, Switzerland) 150 μmol/L was added 1.5 hours before transfection.
| Real-time PCR and cytokine measurement
Real-time PCR analyses for mouse Ido1, Arg1 and Gapdh were carried out using previously reported specific primers. 12 Values were calculated as the ratio of the specific gene to Gapdh expression, as determined by the relative quantification method (ΔΔCT; means ± SD of triplicate determination). 12 Mouse TGF-β (Affymetrix, Santa Clara, USA), IFN-γ and IL-4 (Thermo Fisher Scientific, USA) ELISA kits were used to measure cytokines concentrations in culture supernatants.
| In vivo treatment, skin test assay and flow cytometry
The skin test assay has previously been described. 3, 14 Briefly, puri- 
| Statistical analysis
In vitro data were analysed by unpaired Student's t test. In the skin test assay, paired data were evaluated by paired Student's t test in each group of mice, using the vehicle-injected footpad of individual mice as an internal control. Figure 1A ). IFN-γ, IL-4
| RE SULTS
| Ectopic IL-35Ig induces in vitro
and TGF-β, the most potent inducers of Ido1, Arg1 or both, respectively, 12 were not differentially secreted by DC 35 and DC Ig in culture supernatants at 24 hours post transfection ( Figure 1B) . Therefore, besides the mere production of a tolerogenic cytokine, DC 35 seems to be endowed with an additional suppressive immunometabolic effector mechanism, namely, the expression of Arg1 induced by ectopic IL-35Ig.
| Arg1 is required for the tolerogenic effect of DC 35 in vivo
To confirm the selective involvement of Arg1 ( Figure 1A 
| D ISCUSS I ON
The immunosuppressive role of IL-35 has been observed and confirmed in many different studies, 6 were i.v. transferred into syngeneic C57BL/6 recipient female mice to be assayed for skin reactivity to the eliciting peptide. The minority fractions were purified from either wild-type (wt DC) or Ido1 −/− mice (Ido1 −/− DC) (B), and wild-type DCs was either untreated or pretreated in vitro with the arginase inhibitor nor-NOHA 1.5 h before transfection (C). Skin reactivity of the recipient mice (n = 6 per group) to the eliciting peptide is represented as change in weight of treated footpads vs vehicle-receiving counterparts. Results are representative of two independent experiments (mean ± SD). Significance is referred to a two-tailed paired Student's t test (experimental vs control footpads) in each group of mice. **P < 0.01; ***P < 0. 
